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Abstract.  The mitochondrial matrix enzyme ornithine 
transcarbamylase (OTC) is synthesized on cytoplasmic 
polyribosomes as a precursor (pOTC) with an NH2-ter- 
minal extension of 32 amino acids. We report here 
that rat pOTC  synthesized in vitro is internalized and 
cleaved by isolated rat liver mitochondria in two, tem- 
porally separate steps.  In the first step,  which is de- 
pendent upon an intact mitochondrial membrane po- 
tential, pOTC  is translocated into mitochondria and 
cleaved by a matrix protease to a product designated 
iOTC, intermediate in size between pOTC and mature 
OTC. This product is in a trypsin-protected mitochon- 
drial location. The same intermediate-sized OTC is 
produced in vivo in frog oocytes injected with in 
vitro-synthesized pOTC.  The proteolytic processing of 
pOTC to iOTC involves the removal  of 24 amino acids 
from the NH2 terminus of the precursor and utilizes a 
cleavage  site two residues away from a critical arginine 
residue at position 23.  In a second cleavage  step,  also 
catalyzed by a matrix protease, iOTC is converted to 
mature OTC by removal  of the remaining eight resi- 
dues of leader sequence. 
To define the critical regions in the OTC leader pep- 
tide required for these events,  we have synthesized 
OTC precursors with alterations in the leader.  Substi- 
tution of either an acidic (aspartate)  or a "helix-break- 
ing" (glycine) amino acid residue for arginine 23 of 
the leader inhibits formation of both iOTC and OTC, 
without affecting translocation. These mutant precur- 
sors are cleaved at an otherwise cryptic cleavage  site 
between residues  16 and 17 of the leader.  Interestingly, 
this cleavage occurs at a site two residues away from 
an arginine at position 15. 
The data indicate that conversion of pOTC to ma- 
ture OTC proceeds via the formation of a third dis- 
crete species:  an intermediate-sized OTC. The data 
suggest further that, in the rat pOTC  leader, the essen- 
tial elements required for translocation differ from 
those necessary for correct cleavage to either iOTC or 
mature OTC. 
M 
ost mitochondrial proteins are encoded by nuclear 
genes and synthesized as larger precursors  with 
amino-terminal amino acid extensions referred to 
as "pre-sequences" or "leader peptides" (reviewed in refer- 
ences  13  and  35). These  extensions,  characterized  by the 
presence  of basic amino acid residues  and the absence of 
acidic amino acids, are themselves sufficient to direct uptake 
of the precursor  proteins into mitochondria  (10, 16,  18, 27, 
39). Such uptake can occur posttranslationally (31) and often 
involves translocation across both the outer and inner mem- 
branes. Upon translocation, which requires an electrochemi- 
cal potential across the inner mitochondrial membrane (7, 11, 
19)  and cytosolic nucleoside  triphosphates  (3,  9,  30),  the 
NH2-terminal extensions are processed by a chelator-sensi- 
tive protease(s) localized to the mitochondrial matrix (2, 5, 
23-25). 
The biogenesis of ornithine  transcarbamylase  (OTC),  ~ a 
1. Abbreviations used in thispaper: HMS, buffer containing 220 mM man- 
nitol, 70 mM sucrose, 2 mM Hepes, pH 7.4; iOTC, intermediate ornithine 
transcarbamylase; OTC, ornithine transcarbamylase; pOTC, precursor or- 
nithine transcarbamylase. 
mitochondrial matrix protein of the urea cycle, conforms to 
this model (reviewed in reference 33). OTC is encoded in the 
nucleus, synthesized on free polysomes as a larger precursor 
(pOTC) bearing an NH2-terminal leader peptide, and post- 
translationally imported into mitochondria by a process re- 
quiting a mitochondrial membrane potential (4, 6,  19, 26). 
Processing  of pOTC to its  mature  form requires  a  zinc- 
dependent protease(s) localized to the mitochondrial matrix 
(5, 23-25). 
Previous studies of posttranslational uptake of pOTC into 
isolated mitochondria have shown the production of an OTC 
species,  designated  iOTC, intermediate  in  size  between 
pOTC and mature OTC (1, 19, 20, 22-28). Some workers (1) 
have considered iOTC an in vitro artifact,  while others (19, 
25) have suggested that iOTC may represent a bonafide inter- 
mediate in the mitochondrial uptake pathway. 
In  this  report,  we  present  data  showing  that  iOTC is 
formed  within mitochondria  during  the course  of normal 
biogenesis of OTC by a process that is dependent on a mito- 
chondrial membrane potential, and is catalyzed by a mito- 
chondrial  matrix-localized protease.  Further,  using a tern- 
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converted to OIC. To our knowledge, this is the first demon- 
stration of such two-step cleavage for a matrix-localized mi- 
tochondrial enzyme. Finally, we have investigated the role of 
iOTC in the biogenesis of OTC by making amino acid substi- 
tutions in the leader peptide adjacent to the cleavage site that 
produces iOTC. Such substitutions abolish formation of both 
iOTC and OTC. 
Materials and Methods 
Materials 
Restriction enzymes and other DNA-modifying  enzymes  were obtained 
from New England Biolabs (Beverly, MA).  RNAsin was obtained from 
Promega  Biotec  (Madison,  WI)  and  SP6  RNA  polymerase  was  from 
New England Nuclear (Cambridge,  MA).  [3SS]Methionine, [3H]tyrosine, 
[3H]proline, and [3H]phenylalanine were obtained from Amersham Corp. 
(Arlington Heights, IL). Trypsin, soybean trypsin inhibitor 2,4-dinitrophe- 
nol (DNP), leupeptin, phenylmethylsulfonyl fluoride (PMSF), pepstatin A, 
hexokinase, and tosyl-lysine chloromethyl ketone (TLCK) were from Sig- 
ma Chemical Co.  Rhodamine 6G was from Eastman Kodak Co.  (Roch- 
ester, NY). 
Me~ods 
Construction of Plasmids. An Xba I-Sac II fragment of rat pOTC eDNA 
pR021 (21) and a Sac II-Pst I fi'agment of pOTC- 1 (17) were ligated with Xba 
I/Pst I-cut SP65 plasmid (Promnga Biotec).  Subsequently, the full-length 
pOTC eDNA insert was isolated with minimal flanking sequence from SP65 
by digestion with Msp I and inserted into the Ace I site in the polylinker 
region of pGEM2 (Promega Biotec). The A1-20 construct was generated by 
cutting out a BamH I-BamH I fragment from the full-length pOTC eDNA 
insert and ligating the remaining plasmid. This construct lacks the codon 
for the initiator methionine at position 1 of precursor OTC.  Therefore, the 
peptide translated from an mRNA transcribed from this construct is initi- 
ated at the next inframe codon for methionine, i.e., the codon corresponding 
to amino acid 21 of pOTC. Mutant pOTC constructs encoding leader peptides 
that have the wild type arglnine residue at position 23 replaced with either 
glycine or aspartic acid were prepared by inserting a double-stranded oligo- 
nucleotide  cassette  (49  mer),  with  appropriately  changed  codons,  be- 
tween the unique Nco I site in the leader of pGEM-OTC and the Pvu II site 
at position 12 of mature OTC (21).  The constructs were subsequently se- 
quenced by the method of Sanger et al.  (34)  to ensure that the desired 
changes were made. 
In Vitro Transcription and Translation. For transcription from the SP6 
promoter, the plasmid DNA was linearized with Hha I downstream from 
the T7 promoter. Lineafized plasmid DNA was then used in a transcription 
reaction containing 500 IxM nucleotide triphosphates, 1 lxCi [r  40 
mM Tris-HC! (pH 7.5), 6 mM MgC12, 2 mM DTT, 30 U RNAsin, and 40 
U SP6 polymerase. The reaction was carded out for 90 min at 40~  Ali- 
quots of the transcription mixture were used directly in translation reac- 
tions. Cell-free translation using the rabbit reticulocyte lysate system was 
carried out as previously described (6). 
Incubation of Translation Mixture  with Isolated Mitochondria and 
with Matrix Fraction. Mitochondria were isolated from rat liver as previ- 
ously described (6) and diluted with 220 mM mannitol, 70 mM sucrose, 
2 mM Hepes (pH 7.4) (HMS buffer) to 40 mg/ml total protein. Aliquots of 
the mitochondrial suspension (20 Ixl) were incubated with 20 ~tl of the trans- 
lation mixture (final mitochondrial concentration 20 mg/mi) for 30 min at 
27 or 2~  Products were then analyzed directly by SDS-PAGE as described 
(4). When indicated, mitochondrial import mixtures were treated with tryp- 
sin (final concentration 40 Ixg/ml) for 10 min on ice and then supplemented 
with soybean trypsin inhibitor at a final concentration of 100 ~tg/ml. In some 
experiments, mitochondrial import mixtures were separated into superna- 
taut and mitochondrial pellet by centrifugation in an Eppendorf microfuge 
(Brinkmann Instruments, Inc., Westhury, NY) for 5 rain. Supernatants were 
removed and analyzed directly by SDS-PAGE. Pellets were resuspended in 
mitochondrial isolation buffer (HMS) and then analyzed by SDS-PAGE. 
When indicated, 2,4-dinitrophenol (final concentrations indicated in figure 
legends) was added to 20 I.tl mitochondria (protein concentration 40 mg/ml) 
and the mixture incubated on ice for 10 min before the addition of an equal 
volume of pOIl2-containing translation mixture.  When indicated,  lanes 
were scanned with a  scanning densitometer (Joyce,  Loebl and Co.  Ltd., 
Gateshead, England) and the peaks were integrated planimetricaily. 
A mitochondrial matrix fraction was prepared as described by Conboy 
et al. (5), diluted to 4 mg/ml protein concentration and supplemented with 
MnC12 and ZnC12  (0.1  mM  final concentration).  Wild type and mutant 
precursors synthesized in the reticulooyte lysate translation mixture were 
then added. When effect of prote.ase  inhibitors was being studied, the trans- 
lation mixture was supplemented with an equal volume of a 100,000 g super- 
natant of reticulooyte lysate containing the inhibitor before addition to the 
matrix fraction. Reaction mixtures were incubated for 60 min at 27~  at 
which time the reaction was stopped by addition of immunoprecipitation 
buffer (150 mM NaC1,  10 mM EDTA, 0.5% Triton X-100, 0.25% SDS, 2% 
methionine). Samples were then immunoprecipitated with anti-OTC antise- 
rum and the immunoprecipitates analyzed by SDS-PAGE. 
Oocyte Microinjection Experiments. Female Xenopus laevis were ob- 
tained from the African Xenopus Facility (Clareinch,  Republic of South 
Africa), and were kept on a diet of beef liver and Nasco frog brittle (Nasco 
Biologicals, Fort Atkinson, WI). Stage V-VI oocytes (8) were freed of follic- 
ular tissue by manual dissection, and were maintained in OR-2 saline (40) 
containing penicillin (300 U/ml) and streptomycin (0.3 mg/ml) for injection 
and  subsequent  incubations.  Groups  of  12  oooytes  were  injected  with 
•50  nl of translation mixture containing either pOTC or A1-20 pOTC. After 
incubation for 2 h at 19~  each group of cells was lysed in 500 Ixl 0.1 M 
NaCI,  1% Triton X-100, 0.1%  SDS,  0.5%  Na deoxycholate,  and 0.01 M 
NaPO4, pH 7.4 (38), supplemented with 1 mM PMSF,  1 gM pepstatin A, 
and 2 mM leupeptin (lysis buffer). Cell lysis was accomplished by repeat- 
edly forcing the cells through a Pasteur pipette whose tip had been drawn 
out to a fine bore in a flame. The lysates were centrifuged for 5 min in an 
Eppendorf microfuge (Brinkrnann Instruments, Inc.) and the supernatants 
were  immunoprecipitated  as  previously  described  (6)  and  analyzed  by 
SDS-PAGE. 
Amino Acid Sequencing of Radiolabeled iOTC. ~  precursors were 
synthesized in a rabbit reticulocyte lysate containing 1 mCi of [35S]methio- 
nine,  [3H]phenylalanine,  [3H]tyrosine,  or  [3H]proline.  After  60  rain at 
30~  reactions  were  cooled  on  ice,  MnC12  and ZnCI2  were  added  to 
0.1 mM, and a mitochondrial matrix fraction was added to a final concentra- 
tion of 4 mg/mi matrix protein. Incubation was continued at 16oc for an- 
other 60 min. At that time, all labeled OI~ species were immunopt~cipi- 
tated with anti-OTC antiserum and the immune complexes were adsorbed 
with protein A-Sepharose. Adsorbed proteins were eluted by adding 3 vol 
of 125 mM Tris, pH 6.8, 2% SDS, and 5% [3-mercaptocthanol and heating 
for 3 min at 60~  The SDS buffer was diluted with 5 mM (NI-h)2HCO3, 
0.01%  Triton X-100  and the sample was  concentrated using a  centricon 
microfiltration device (Amicon Corp., Danvers, MA). Cold rat OTC protein 
(5 amoles) was added as carrier, and the protein was precipitated for 1 h 
on ice with 20% "IV_A. The acetone-washed pellet was suspended in 100% 
trifluoroacetic acid,  immediately loaded on a gas-phase sequenator (Ap- 
plied Biosystems, Inc., Foster City, CA) and subjected to automated Edman 
degradation. 90% of each cycle was used for scintillation counting, and 10% 
was taken out for ion-exchange HPLC of phenylthiohydantoin-amino acids. 
The first cycle yield from the carrier OTC was 20-40%;  the yield from 
repetitive cycles was 90-95 %. 
Results 
1free Course of  pOTC Import Suggests that iOTC 
Is an Intermediate 
The  time  course  of tK)TC  internalization  was  examined 
by incubating isolated rat liver mitochondria with pOTC- 
containing translation mixture at 27~  At each time point an 
aliquot of the import mixture was removed and the products 
analyzed by SDS-PAGE. As shown in Fig.  1 A, incubation 
of the pOTC-containing translation mixture (lane Tr) with 
mitochondria at 27~  leads to the conversion of pOTC into 
intermediate and mature-sized polypeptides. The amount of 
pOTC decreased steadily with time while the intensity of the 
mature OTC band increased steadily.  Whereas no iOTC was 
detected at zero time, its intensity was maximal at 2 min of 
incubation and then decreased. Quantitation of this fluoro- 
graph by densitometric analysis is presented in Fig. 1 B. The 
observed kinetics are consistent with (but do not prove) a 
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chondria were incubated with translation mixture containing pOTC 
(lane Tr) at 2"/~  At each time point a 5-~tl aliquot of the import 
mixture  was removed and directly  analyzed by SDS-PAGE. (B) 
Fluorograph from A was quantitatively evaluated by densitometry. 
Actual readings (in arbitrary units) at 0, 2, 6, 10, 20 min were: 63, 
55, 30, 25, 17 for pOTC; 0, 19, 18, 6, 5 for iOTC; and 0, 21, 39, 55, 
56 for OTC, respectively. (The ordinate represents % of maximal 
level attained by each OTC species between 0 and 20 min.) 
precursor-product relationship  between  pOTC  and  iOTC 
and between iOTC and OTC. 
Both iOTC and Mature OTC Are Localized 
within Mitochondria 
Previous results on the posttranslational import of  pOTC into 
isolated mitochondria have been interpreted to suggest that 
either iOTC is a  bonafide intermediate in OTC biogenesis 
(19), or that iOTC is an artifact of the in vitro uptake systems 
(1). To examine these two general possibilities, we incubated 
mitochondria with pOTC-containing translation mixture at 
27~  for 60 min, then separated the mitochondrial import 
mixture into mitochondrial pellet and supernatant fractions, 
and analyzed each by SDS-PAGE. As seen in Fig. 2 A, lane 
T, iOTC and mature OTC were produced during the incuba- 
tion at the expense of  pOTC (lane Tr). When this import mix- 
ture was centrifuged, only pOTC was found in the superna- 
tant fraction (Fig. 2 A, lane S), while iOTC and OTC were 
found exclusively in the mitochondrial pellet (lane P) frac- 
tion. Some pOTC was recovered with the mitochondrial pel- 
let as well; this could represent precursor either specifically 
bound to a surface receptor or nonspecifically adsorbed to 
the mitochondrial surface. 
To determine the topology of iOTC,  i.e., to test whether 
it  is  associated  with  the  surface  of the  mitochondria  or 
whether it has been translocated across the mitochondrial 
outer membrane, we tested its sensitivity to trypsin (Fig. 2 
B). Translation mixture (Fig. 2 B, lane Tr) containing pOTC 
(and a small amount of A1-20 band which arises in the cell- 
free translation mixtures as a result of variable initiation at 
the internal methionine at position 21) was incubated with 
mitochondria; the total import mixture was then treated with 
trypsin and analyzed by SDS-PAGE (lanes T). Trypsin treat- 
ment resulted in total degradation of pOTC (and A1-20) and 
almost complete recovery of both iOTC and mature OTC. 
These data indicate that iOTC represents a mitochondrially 
associated, trypsin-protected species. 
As mentioned earlier, Argan et al. (1) have dismissed iOTC 
as a nonmitochondrial in vitro product generated either by 
a "leaked" mitochondrial matrix protease or a contaminating 
protease of some other origin. They have presented evidence 
that, in their hands, iOTC was not localized within heart mi- 
tochondria but rather was recovered in the supernatant frac- 
tion of an import mixture. We do not find this to be the case 
when rat liver mitochondria are used in the import reaction. 
Indeed,  as  shown  in  Fig.  2,  virtually  all  of the  iOTC 
formed during a 60-rain incubation at 27~  was associated 
with the mitochondrial pellet and was protected from tryp- 
sin digestion,  indicating localization within the organelle. 
Therefore, we posited that the discrepancy between our re- 
suits and those of Argan et al.  (1) might reflect differences 
in the intactness of  mitochondria isolated from rat liver com- 
pared with those isolated from rat heart. It should be noted 
that preparation of heart mitochondria requires much longer 
homogenization of  the tissue and hence could lead to produc- 
tion of more damaged mitochondria. To test this possibility, 
we exposed rat liver mitochondria to additional homogeniza- 
tion before using them in an import reaction. Such additional 
handling results in the isolation of mitochondria that leak, 
i.e., release some of  their matrix content into the supernatant 
as evidenced by the release of significant amounts of mature 
OTC.  Leaky mitochondria prepared in  this  way were in- 
cubated with translation mixture containing ptYl'C at 270C. 
At selected time points, an aliquot of the import mixture was 
taken and the products were analyzed by SDS-PAGE. The 
results are shown in Fig.  3 A and closely match the time 
course of iOTC and OTC formation observed by Argan et al. 
(1). The amount of pOTC declined concomitantly with an in- 
crease in levels of  iOTC and mature OTC. Comparison of  this 
fluorograph to that in Fig.  1 A shows that the appearance of 
Figure 2.  Both iOTC and ma- 
ture OTC are localized with- 
in mitochondria. (A) Isolated 
mitochondria were incubated 
with translation mixture con- 
mining pOTC (lane Tr) at 27~ 
for 60 min. After that time an 
aliquot (5 gl) of the total im- 
port mixture was analyzed by 
SDS-PAGE (lane T). Another 
aliquot was supplemented  with 
50 gl HMS and centrifuged in 
a microfuge for 2 min. The su- 
pernatant  was  removed  and 
analyzed by SDS-PAGE (lane S).  The mitochondrial pellet was 
resuspended in 50 gl HMS and then analyzed by SDS-PAGE  (lane 
P).  Equivalent mounts of supernatant and mitochondrial pellet 
fraction were loaded.  (B) Isolated mitochondria were incubated 
with translation mixture containing pOTC (lane  Tr) at 27~  for 
60 rain.  An aliquot of the total import mixture was analyzed by 
SDS-PAGE (lane  T  -  trypsin).  Another aliquot was treated with 
trypsin as described in Materials and Methods and then analyzed 
by SDS-PAGE  (lane T + trypsin). A1-20  product is the result of in- 
ternal initiation at methionine at position 21 of the leader; it is not 
internalized by mitochondria. 
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by damaged mitochondria. (,4) 
Isolated mitoc~  were sub- 
jected  to  additional  homog- 
enization  (see  text  for  de- 
tails) and then incubated with 
translation  mixture  contain- 
ing pOTC (lane Tr) at 27~  At 
each time point a 5-tal aliquot 
of  the  import  mixture  was 
removed  and analyzed  by SDS- 
PAGE. (B) Isolated mitochon- 
dria  were  subjected to addi- 
tional homogenization and then incubated with translation mixture 
containing pOTC at 27~  for 60 min. An aliquot of the total import 
mixture was analyzed by SDS-PAGE  (lane T). A second aliquot was 
supplemented with HMS and centrifuged. The supematant was re- 
moved and analyzed by SDS-PAGE  (lane S  -  trypsin). The mito- 
chondrial pellet was resuspended in HMS and analyzed by SDS- 
PAGE (lane P -  trypsin). A third aliquot was treated with trypsin 
as described in Materials and Methods and then separated by cen- 
trifugation into supernatant and pellet. Each fraction was then ana- 
lyzed by SDS-PAGE  (lanes S + trypsin and P  + trypsin, respec- 
tively). 
OTC is significantly delayed and reduced in the damaged mi- 
tochondria. The kinetics of iOTC appearance also show a 
dramatic difference: in "healthy" mitochondria (Fig.  1 A) 
iOTC appearance shows a discrete early peak; in leaky ones 
(Fig. 3 A), iOTC rises almost linearly with time from 0 to 
20 rain of incubation. The latter kinetics would be expected 
if pOTC was being cleaved in the supernatant by a released 
matrix protease. To test this hypothesis further, we incubated 
damaged  mitochondria  with  pOTC-containing  translation 
mixture at 27~  for 60 rain and then separated the import 
mixture into supernatant  and  mitochondrial fractions.  As 
shown in Fig.  3 B, lane T, iO'IC and OTC were generated 
during  the  incubation.  Upon  separation,  the  majority of 
iOTC was recovered in the supernatant, the majority of OTC 
was recovered in the pellet, and pOTC was present in both 
fractions. After trypsin treatment, pOIC, iOTC, and ~  in 
the supernatant were completely degraded, while, in the pel- 
let, some iOTC and OTC were protected but pOTC was not. 
Based on these data, we conclude that the intermediate- 
sized OTC species produced by damaged mitochondria is, in- 
deed, produced by a protease released from mitochondria 
and  is  not related to  import.  However, our data  (Fig.  2) 
clearly show that under our conditions of import, the amount 
of such extramitochondrial iOTC produced is so low as to be 
undetectable, and that the iOTC which we observe is a mito- 
chondrially located form. 
Formation of  iOTC Requires an Intact Mitochondrial 
Membrane Potential 
Normal uptake of pOTC (as measured by formation of ma- 
ture OTC) requires an intact mitochondrial membrane poten- 
tial (19, 26). To test whether iOTC formation depends on the 
same uptake mechanism as formation of OTC, we incubated 
pOTC-containing translation mixture with mitochondria that 
had been treated with the uncoupler, DNP. In the presence 
of DNP, the electrochemical gradient across the mitochon- 
drial inner membrane collapses, and ATP is degraded as the 
Figure 4. DNP inhibits formation 
of iOTC. DNP was added to iso- 
lated mitochondria at a concen- 
tration of 50 or  1130 gM.  After 
10 min on ice, pOTC-containing 
translation mixture was added and 
the import mixture incubated at 
27~  for 30 min.  Mitochondria 
were isolated by centrifugation and analyzed by SDS-PAGE. Lane 
1, no DNP; lane 2, 50 taM DNP; lane 3, I00 taM DNP. 
mitochondrial membrane ATPase is uncoupled from elec- 
tron transport. In the presence of 50 or 100 laM DNP (Fig. 
4, lanes 2 and 3, respectively), production of both iOTC and 
OTC was inhibited.  This is  further evidence that iOTC is 
formed during the course of normal uptake of  pOTC into mi- 
tochondria because uncoupling of mitochondria in the  in 
vitro uptake reaction should have no effect on the action of 
an  extramitochondrial protease.  In  the presence of DNP, 
only small amounts of pOTC were recovered with the mito- 
chondria (most of the input pOTC was present in the super- 
natant of an import mixture) and probably represents pOTC 
nonspecifically bound  to  the  mitochondrial surface.  This 
suggestion is based on our results (data not shown) that DNP 
prevents binding of pOTC to mitochondria in vivo. Trypsin 
treatment of a DNP-blocked import mixture led to complete 
degradation of pUIX2 (data not shown). 
iOTC Can Be "Chased" into Mature OTC 
As shown in Fig. 5, lane 1, incubation of an import mixture 
at 16~  results in formation of approximately equal amounts 
of iOTC and OTC. Therefore, we could address the question 
Figure 5. Conversion of iOTC 
into  mature  OTC. Isolated 
mitochondria were incubated 
with  pOTC-containing trans- 
lation mixture  for 30 min at 
16~  (lane  1).  The  import 
mixture  incubated  at  16~ 
was supplemented with tryp- 
sin and incubated on ice for 
10 min. At that time, ST1 was 
added and the sample was di- 
vided into two portions. One 
was  analyzed by SDS-PAGE 
(lane 2), while the other was 
incubated at 27~  for 30 min 
and  then  analyzed  by  SDS- 
PAGE (lane 3). Densitometric 
tracings of the autoradiogram 
are shown below the photo- 
graph. 
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containing translation mixture was supplemented with ZnCI2 (0.1 
mM), MnC12 (0.1 mM), and 100,000 g supernatant of reticulocyte 
lysate containing specific inhibitor. Mitochondrial matrix fraction 
was added to 4 mg/ml final protein concentration, and the mixture 
was incubated at 27~  for 60 min (lanes 3-8) or at 16~  for 30 min 
(lane 2). The reaction was stopped by adding immunoprecipitation 
buffer. The OTC species were immunoprecipitated  and the immu- 
noprecipitates analyzed by SDS-PAGE. Lane 1, pOTC-containing 
translation mixture; lane 2, pOTC-containing  translation mixture 
plus matrix fraction incubated at 16~  lane 3, pOTC-containing 
translation mixture plus matrix fraction incubated at 27~  lane 4, 
as in lane 3 plus leupeptin (2 mg/ml); lane 5, as in lane 3 plus pep- 
statin A (2 mg/ml); lane 6, as in lane 3 plus 1,10-phenanthroline 
(5 mM); lane 7, as in lane 3 plus rhodamine 6G (40 lxg/ml); lane 
8, as in lane 3 plus 50 U/ml hexokinase and 0.1 M glucose. 
as to whether iOTC is a direct precursor of OTC. Mitochon- 
dria were incubated with pOTC-containing translation mix- 
ture for 30 min at 16~  Treatment of this import mixture 
with trypsin led to the complete disappearance of  pOTC (Fig. 
5, lane 2). Subsequent incubation of this reaction mixture at 
27~  led to a marked decrease in the intensity of the iOTC 
band with a concurrent and parallel increase in the intensity 
of OTC (Fig. 5, lane 3). Densitometric quantitation of lanes 
2  and 3 (shown below the gel in Fig. 5) reveals that iOTC 
is converted to OTC  with •50%  efficiency.  These results 
show that iOTC is a direct precursor of OTC. 
A Mitochondrial Matrix Fraction Cleaves pOTC to iOTC 
To further characterize the pOTC to iOTC cleavage, we in- 
cubated pOTC with an isolated mitoehondrial matrix frac- 
tion, prepared as described by Conboy et al. (5). The matrix 
fraction cleaved pOTC to both iOTC and OTC (Fig. 5, lanes 
2 and 3). In an attempt to selectively inhibit iOTC formation, 
we tested a number of protease inhibitors for their effect on 
the matrix-catalyzed  cleavage. The protease inhibitor pepsta- 
tin A (1 mg/ml) and the chelating agent 1,10-phenanthroline 
(5 mM), each inhibited formation of mature OTC without 
substantially inhibiting iOTC formation (Fig. 6, lanes 5 and 
6).  Leupeptin (2 mg/ml) reduced formation of both iOTC 
and OTC  (Fig. 6,  lane 4),  while rhodamine 613 and ATP 
depletion had no effect (Fig. 6, lanes 7 and 8). Significantly, 
we  did  not  find  an  inhibitor  that  specifically  inhibited 
production of iOTC  while allowing OTC  production. Be- 
cause we could build up intermediate under conditions (16~ 
incubation) in which little OTC was produced (Fig. 6, lane 
2), we used this system to produce sufficient iOTC to define 
the sequence of the NH2 terminus of the iOTC peptide. 
iOTC Is Produced by Cleavage within the 
pOTC Leader Sequence 
To establish that the apparent difference in molecular weight 
between  iOTC  and  either  pOTC  or  mature  OTC  reflects 
cleavage  of  a  part  of  the  pOTC  leader  and  not  some 
modification merely  altering  electrophoretic  mobility on 
SDS-PAGE,  we sequenced the  amino terminus of iOTC. 
Precursor OTC was synthesized in a reticulocyte lysate in the 
presence  of  [3H]tyrosine or  [3H]proline.  The  translation 
mixture was incubated with a mitochondrial matrix fraction 
at 16~  (under conditions which favor iOTC production) and 
then immunoprecipitated with anti-OTC antiserum. The im- 
munoprecipitated material was eluted from protein A-Sepha- 
rose, dialyzed, and subjected to automated Edman degrada- 
tion  (Fig.  7).  [3H]Tyrosine  and  [3H]proline  were  chosen 
because these amino acids are found in the region of the 
pOTC leader expected to be retained in iOTC. Importantly, 
they are  not  found in the amino-terminal portion of the 
leader; thus, no label would be released from any residual 
pOTC in the immunoprecipitate. Radioactivity released dur- 
ing  Edman  degradation  of  [3H]tyrosine-labeled  material 
was detected in cycle 3; when material was radiolabeled with 
[3H]proline,  radioactivity was detected in cycle 6. The num- 
bering of each cycle of Edman degradation was checked by 
analyzing amino acids released during each cycle from car- 
rier mature OTC  and comparing them with the sequence 
of mature OTC. In the cycle in which [3H]tyrosine was re- 
leased, cold valine was detected and in the cycle containing 
[3H]proline,  cold lysine was present. Comparison with the 
amino acid sequence deduced from the eDNA sequence (21; 
see Fig. 7) shows, therefore, that the cleavage site used in 
production of iOTC is between residues 24 (asparagine) and 
25 (phenylalanine) of the leader. 
iOTC Is Formed In Vivo 
The data presented thus far define parameters ofiOTC forma- 
tion and conversion to OTC by isolated rat liver mitochon- 
dria.  To eliminate the possibility that generation of iOTC 
Figure 7. Sequence  analysis  of iOTC.  Amino acid sequence of 
pOT(2  deduced from  the  eDNA sequence  (21).  Arrow indicates  the 
cleavage  site  to  produce  iOTC;  arrowhead indicates  the  cleavage  site 
to  produce mature UIC. Location  of  labeled  amino  acids,  tyrosine 
(circled)  and proline  (boxed),  are indicated.  Precursor  O'IC was 
synthesized  in reticulocyte  lysate  in the presence of [3H]tyrosine 
(left) or [3H]prolinc (right). Intermediate OTC was prepared for 
sequencing as described in Materials and Methods and subjected 
to Edman degradation. 
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formed in vivo. Frog ooeytes 
were  injected  with  transla- 
tion mixture containing either 
pOTC or AI-20 OTC and in- 
cubated at 19"C for 120 min. 
Oocytes were then lysed in the presence of proteolytic inhibitors, 
the lysates were immunoprecipitated, and the immunoprecipitates 
were analyzed by SDS-PAGE. Lanes 1 and 2, immunoprecipitated 
polypeptides from cells injected with pOTC or A1-20  OTC--contain- 
ing translation mixtures, respectively. 
represents an artifactual (but mitochondrial) cleavage due to 
the disruption of mitochondria during their isolation, we ex- 
amined the import of rat pOTC in an intact cell, i.e., in the 
frog oocyte. This experimental system eliminates the possi- 
ble mitochondrial damage which might occur during liver 
homogenization  and  fractionation.  Translation  mixtures 
containing either p(YI~ or A1-20 pOTC were injected into 
oocytes. Since A1-20 ~  is neither taken up by rat liver 
mitochondria nor cleaved (22; and Fig. 2), this mutant poly- 
peptide acts as a control in the oocyte system. After injec- 
tion, the cells were incubated for 120 min at 19~  and then 
lysed by addition of lysis buffer (see Materials and Methods) 
containing protease inhibitors. The lysates were immunopre- 
cipitated and analyzed by SDS-PAGE. As shown in Fig.  8, 
pOTC, iOTC and OTC could be detected in oocytes injected 
with pOTC-containing  translation mixture while  only the 
starting material, A1-20 pOTC, was seen in oocytes injected 
with  A1-20  pOTC-containing translation  mixture.  Recent 
results with OTC precursors expressed in vivo in transfected 
HeLa cells have also revealed an intermediate during import 
of human OTC in vivo (data not shown). 
Mutations Introduced Adjacent to iOTC Cleavage 
Site Abolish Production of  Normal iOTC and OTC 
As a further test of the importance of iOTC in the production 
of OTC, we attempted to disrupt the cleavage site between po- 
sition 24 and 25 by introducing novel amino acids into the 
pOTC sequence. We chose as our target the arginine at posi- 
tion 23 of the leader for several reasons:  (a) an abundance 
of arginine residues is the one common feature of all mito- 
chondrial  leader  peptides  sequenced  thus  far;  (b)  while 
characterizing a partially purified, leader peptide-cleaving 
mitochondrial protease, Miura et al. (23) suggested that most 
leaders that are cleaved by a chelator-sensitive matrix pro- 
tease have a basic amino acid residue at position -2 or -3 
relative to the cleavage site; and (c) substitution of a glycine 
for arginine 23 of  the human pOTC leader abolishes cleavage 
of that precursor to mature OTC (15). 
The arginine at position 23 of the rat ~  leader was 
changed  to  either  glycine  or  aspartic  acid  by  standard 
methods of in vitro site-directed mutagenesis. The mutant 
precursors were synthesized in the rabbit reticulocyte lysate 
system, and the translation products were incubated with iso- 
lated mitochondria. As shown in Fig. 9 A, both precursors 
were cleaved to a novel OTC species, whose gel mobility was 
intermediate between pOTC and the "A1-20" band.  In the 
case of the asp 23 substitution, the novel cleaved form was 
the only "new" product detected after incubation of the mu- 
tant precursor with mitochondria. Whereas the novel cleav- 
age product was also the predominant product formed from 
the gly 23 mutant precursor, longer exposures of the fluoro- 
graph revealed weak bands corresponding to iOTC and OTC. 
Since inhibition of OTC production corresponds in each case 
with inhibition of iOTC production,  we conclude that the 
production of OTC  is  tightly linked  to  the production of 
iOTC. 
The Novel Cleavage Form Is the Product of 
Mitochondrial Import and a Matrix Protease 
We incubated both the asp 23 and the gly 23 mutant precur- 
sors with isolated mitochondria to establish whether the for- 
mation of the novel cleavage products reflected import of the 
mutant precursor and cleavage by a matrix protease. Because 
analogous results were obtained for asp 23 and gly 23 mu- 
Figure 9.  Effect of position 23 substitution on import.  (A) SP6- 
derived plasmids with the designated codon substitutions were tran- 
scribed in vitro and the products used to direct reticulocyte lysate 
translation reactions containing [35S]methionine. After translation, 
an aliquot of each mixture was inununoprecipitated and analyzed 
by SDS-PAGE (lanes -  mitochondria). A second aliquot was in- 
cubated for 30 min at 27~  with isolated mitochondria and then 
analyzed (lanes + mitochondria). Arg 23 represents the wild type 
OTC precursor. Arrow points to a novel OTC species. (B) Asp 23- 
containing translation mixture (lane 1) was incubated for 30 min 
at 27~  with isolated mitochondria (2 mg/ml) plus 50 mM DNP 
(lane 2) or without added DNP (lanes 3 and 4). An aliquot of the 
import mixture without DNP was incubated at 0~  for another 20 
rain with 0.25  mg/ml proteinase K  (lane 4).  The reaction was 
stopped by addition of  PMSF to 2 raM, and all samples were immu- 
noprecipitated and analyzed by SDS-PAGE  as described before. (C) 
Asp 23 pOTC-containing translation mixture (lane -  matr/x) was 
supplemented with  isolated  matrix  fraction  (see  Materials  and 
Methods for protocol) and incubated at 16~  for 30 min (lane + 
matr/x). Samples were then immunoprecipitated and analyzed by 
SDS-PAGE. 
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raining translation mixture was incubated with mitochondria 
(Fig. 9 B, lane 3) and then proteinase K was added to the 
reaction mixture (Fig. 9 B, lane 4). As expected for an im- 
ported protein, the new product is protected from externally 
added protease, while most of the precursor and the unim- 
portable A1-20 are degraded. 
The results of incubation of asp 23 precursor with mito- 
chondria in the presence of DNP are presented in Fig. 9 B, 
lane 2. No cleavage to the novel product was observed in the 
presence of inhibitor, as would be expected if cleavage fol- 
lows the normal uptake which is dependent on a mitochon- 
drial membrane potential. 
To  further characterize  the cleavage of the  mutant rat 
precursors, we incubated asp 23 and gly 23 pOTCs with a 
soluble  matrix  fraction  from  rat  liver  mitochondria.  As 
shown in Fig. 9 C, asp 23 precursor was cleaved by the solu- 
ble  matrix fraction to a  product migrating with mobility 
identical to the product seen after incubation with intact 
mitochondria. Analogous results were obtained for gly 23 
pOTC (data not shown). 
Identification of the "Cryptic" Cleavage Site 
Because we were interested in the novel cleavage site that is 
used in the gly 23- and asp 23-substituted rat OTC precur- 
sors, we used the matrix fraction to prepare [~H]phenylala- 
nine- and [35S]methionine-labeled asp 23 and gly 23 cleavage 
products for radiosequencing. We used either [3H]phenyl- 
alanine or [35S]methionlne in the translation mixture, reason- 
ing that these labels would be close to the amino terminus 
of an intermediate species which was apparently longer than 
the A1-20 internal initiation product. As shown in Fig.  10, 
label  from [3H]phenylalanine-labeled material was recov- 
ered in cycle 9,  while label from [35S]methionine-labeled 
Figure 10. Sequence analysis  of novel  OTC species. Amino acid se- 
quence of  pOTC deduced from the eDNA sequence (21). Arrow in- 
dicates location of the cleavage site to produce novel OTC species. 
Positions of labeled amino acids, phenylalanine (triangle) and me- 
thionine (diamond), are indicated. Mutant pOTC (asp 23) was syn- 
thesized in reticulocyte lysate in the presence of [3SS]methionine 
(/eft) or [3H]phenylalanine  (right). Precursor was cleaved by a ma- 
trix fraction as shown  in Fig. 9 C, the radiolabeled proteins were 
prepared for sequencing  as described in Materials and Methods and 
subjected to Edman degradation. 
material was recovered in cycles 1 and 5. This maps the asp 
23  novel cleavage site between residues  16 and  17  of the 
pOTC leader.  The methionine label released in cycle 1 is 
from the pOTC and A1-20 which remain in the sequenced 
sample (see Fig. 9 C for an example of the material that was 
sequenced). We have also determined that the major product 
formed during incubation of gly 23 substituted pOTC with 
mitochondria is cleaved between residues  16 and 17 (data 
not shown). 
Discussion 
During the nearly ten years that the biogenesis of OTC has 
been investigated, a rat OTC species (iOTC) intermediate in 
size between the precursor and the mature form of OTC has 
been observed repeatedly in this and in a number of other 
laboratories. The precise significance of this molecule, how- 
ever,  has not been defined. While some (19, 25) have pro- 
posed that iOTC represents a bona fide intermediate in the 
mitochondrial import pathway of OTC, others (1) have con- 
cluded that the appearance  of iOTC  is  due to artifactual 
cleavage of pOTC and is not part of the physiologic pathway 
of mitochondrial import and cleavage. In this report we pre- 
sent data that define iOTC as a true intermediate in the mito- 
chondrial import pathway of OTC. This conclusion is based 
upon the following findings: (a) iOTC produced in an import 
reaction containing undamaged mitochondria is recovered in 
the mitochondrial pellet; (b) iOTC produced at 27~  is tryp- 
sin protected, suggesting intramitochondrial localization; (c) 
iOTC can be converted directly to mature OTC; (d) iOTC is 
not produced in the presence of an uncoupler of oxidative 
phosphorylation, indicating that cleavage occurs only after 
pOTC is internalized by mitochondria; (e) iOTC is produced 
in intact cells, thereby excluding the possibility that its ap- 
pearance is due to damaged mitochondria or to some other 
artifact inherent in the in vitro protocols; and (f) substitu- 
tions near the iOTC cleavage site inhibit formation of both 
iUYC and mature OTC. 
The production of intermediates in the biogenesis of mito- 
chondrial enzymes has been noted before. Partially cleaved 
forms of yeast cytochrome b2 (29, 32) (a soluble enzyme of 
the intermembrane space), cytochrome c~ of yeast (12, 29) 
and Neurospora  (36), Fe/S protein of ubiquinol-cytochrome 
c reductase (14) (proteins located in the inner membrane and 
exposed to the intermembrane space), and ATPase subunit 
9 (37) (inner membrane protein) have been demonstrated in 
vitro and in vivo.  These precursors are first cleaved within 
the leader to an intermediate form by a matrix-located pro- 
tease, then cleaved again by a protease located either in the 
matrix (37) or in the intermembrane space (29, 32). The two- 
step processing which has been described for the precursors 
of yeast cytochrome b2 and the Fe/S protein of Neurospora 
has been  shown to be important in determining the sub- 
rnitochondrial localization of these enzymes. After translo- 
cation, cytochrome b2 precursor is cleaved to produce an 
intermediate containing a domain spanning the inner mito- 
chondrial membrane and majority of the protein protruding 
into the intermembrane space. In the second cleavage step, 
the membrane domain is removed, resulting in the release 
of soluble enzyme into the intermembrane space. The Fe/S 
protein precursor  is  translocated entirely into the matrix 
where the extreme NH2 terminus of the leader peptide is 
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tide then acts as a "signal peptide" and directs the transfer of 
the mature portion of the protein back across the inner mem- 
brane. Once transfer  is complete, a protease located outside 
the inner mitochondrial membrane removes the remaining 
portion of the leader. 
To our knowledge this is the first report describing a ma- 
trix enzyme precursor that is cleaved twice during its biogen- 
esis. Why a second cleavage event has evolved (or persisted) 
in the biogenesis  of OTC  is  unclear.  Since  both cleavage 
events occur in the mitochondrial matrix, the portion of the 
leader peptide left on iOTC is probably not a submitochon- 
drial sorting signal. In the absence of an obvious role for two- 
step proteolysis of pOTC, we are considering three different 
models for the process: (a) Possibly the observation of iOTC 
cleavage as a distinct step in leader peptide removal merely 
reflects an unusually slow step in what is usually (for other 
precursors) a rapid concerted series of leader peptide cleav- 
ages. Supporting this notion of processive proteolysis is the 
observation that during in vitro import of the human OTC 
precursor, iO'lE is an extremely short-lived species (data not 
shown). (b) Initiation of assembly of active OTC trimers may 
depend on release of OTC from a translocator-bound iOTC 
or on formation of a precise  OTC  NH~ terminus by trim- 
ming of iOI~.  The ensuing delay in folding of the translo- 
cated protein might allow time for interaction with additional 
subunits in order to facilitate trimer formation. (c) A second 
import channel might have arisen which is associated with 
a different, chelator-insensitive, mitochondrial protease that 
produces only intermediate from pOTC. Subsequent conver- 
sion of this iOTC to OTC would then require cleavage by an- 
other, more general, leader peptide protease. 
We have shown that certain amino acid substitutions in the 
rat pOq~ leader adjacent to the iOTC cleavage site inhibit 
formation of iOTC and mature OTC. These substitutions al- 
low translocation of the altered precursors but lead to a for- 
mation of a novel form of OTC cleaved between residues 16 
and 17 of the leader.  In a recent paper, Nguyen et al.  (28) 
have  shown that deletion  of residues  22-30  of this  same 
precursor  has  similar  effects:  translocation of the altered 
precursor without cleavage to mature OTC,  and inefficient 
cleavage of the translocated precursor at a new site within the 
leader peptide. 
Several explanations for the effect of position 23 substitu- 
tion and deletion of position 23 on formation of mature OI~ 
can be put forward. If iOTC is an obligate precursor to OTC, 
then interfering with iOTC cleavage would also inhibit OTC 
production. Alternatively, the critical peptide structure de- 
termined by arginine 23 may present both iO'IE  and OTC 
cleavage sites to the active site or sites of one or more matrix 
proteases. In this second case, the critical conformation must 
be held intact after removal of amino acid residues 1-24, be- 
cause we have clearly demonstrated that iOI~ formed in iso- 
lated mitochondria can be cleaved to Oil. 
Each of the above models makes  specific predictions re- 
garding the number and specificities of mitochondrial matrix 
proteases. We are currently isolating the protease responsi- 
ble for each of the steps of pOTC conversion to OTC in order 
to define whether formation of iO'lC is an obligatory step in 
O1"I2 production. 
We are grateful to Dr. George Palade, Dr. Wayne Fenton, and Peter Hedges 
for helpful discussions during these studies and comments during prepara- 
tion  of the  manuscript. We wish to  acknowledge Kathy Stone and  Ray 
DeAngelo at the Yale  Protein Chemistry facility for their effort and in- 
genuity in sequencing a  troublesome  series of radiolabeled  samples and 
Manju Swaroop for excellent technical assistance. We also thank Connie 
Woznick for expert secretarial help. 
This study was supported by  a  grant from the National  Institutes  of 
Health (DK09527).  E S. Sztul was supported by a postdoctoral fellowship 
from the American Cancer Society. 
Received for publication 18 December 1986, and in revised form 24 August 
1987. 
References 
1. Argan, C., C. J. Lusty, and G. C. Shore.  1983. Membrane and cytosolic 
components,  affecting  transport  of  the  precursor  for  ornithine  car- 
bamyltransferase into mitocbondria. J.  Biol. Chem. 258:6667-6670. 
2. Bohni, P. C., G. Daum, and G. Schatz. 1983. Import of proteins into mito- 
chondria.  Partial  purification  of a  matrix-located protease involved in 
cleavage of mitochondrial precursor polypoptides.  J.  Biol. Chem. 258: 
4937-4943. 
3. Chen, W. J., and M. C. Douglas. 1987. Phosphodiester bond cleavage out- 
side mitochondria is required for completion of protein import into the 
mitocbondrial matrix. Cell. 49:651-658. 
4. Conboy, J., and L. E. Rosenbcrg. 1981. Posttranslational uptake and pro- 
cessing of in vitro synthesized  ornithine transcarbamoylase precursor by 
isolated rat liver mitchondria.  Proc. Natl. Acad. Sci. USA. 78:3073-3077. 
5. Conboy, J. G., W. A. Fenton, and L. E. Rosenberg. 1982. Processing of 
pre-ornithine transcarbamylase requires a zinc-dependent protease local- 
ized to the mitochondrial matrix. Biochem. Biophys. Res. Commun. 105: 
1-7. 
6. Conboy, J. G., F. Kalousek, and L. E. Rosenberg. 1979. In vitro synthesis 
of  a  putative precursor of mitochondrial ornithine transcarbamylase. 
Proc. Natl. Acad.  Sci. USA. 75:5724-5727. 
7. Daum, G., S. M. Gasser, and G. Schatz. 1982. Import of proteins into mito- 
chondria. Energy-dependent, two step processing of the intermembrane 
space enzyme cytochrome be by isolated  yeast mitocbondria. J.  Biol. 
Chem. 257:13075-13080. 
8.  Dumont, J. N.  1972. Oogenesis in Xenopus laevis (Daudin). 1. Stages of 
oocyte development in laboratory maintained animals. J. Morphol.  136: 
153-180. 
9. Eilers, M., W. Oppliger, and G. Schatz. 1987. Both ATP and an energized 
inner membrane are required to import a purified  precursor protein into 
mitochondria. EMBO  (Fur. MoL  Biol. Organ.) J.  6:1073-1078. 
10. Emr, S. D., A. Vassarotti, J. Garrett, B. L. Geller, M. Takeda, and M. G. 
Douglas. 1986.  The amino terminus of the yeast F~-ATPase [3-subunit 
precursor functions as a mitochondrial import signal. J.  Cell Biol.  102: 
523-533. 
11. Gasser, S. M., G. Daum, andG. Schatz. 1982. Import of proteins into mito- 
chondria. Energy dependent uptake of precursors by isolated  mitochon- 
dria. J.  Biol. Chem. 257:13034-13041. 
12. Gasser, S. M., A. Ohashi, G. Daum, P. C. Bohni, J. Gibson, G. A. Reid, 
T.  Yonetani,  and  G.  Schatz.  1982.  Imported mitochondrial proteins 
cytochrome b2 and cytochrome c~  are processed in two  steps.  Proc. 
Natl. Acad. Sci. USA. 79:267-271. 
13. Hay, R., P. Bohni, and S. Gasser. 1984.  How mitochondria import pro- 
teins. Biochim. Biophys. Acta. 779:65-87. 
14. Hartl, F. U., B. Schmidt, E'. Wachter, H. Weiss, and W. Neupert.  1986. 
Transport into mitochondria and intramitochondrial sorting of the Fe/S 
protein of ubiquinol-cytochrome c reductase. Cell. 47:939-951. 
15. Horwich, A. L., F. Kalousek, W. A. Fenton, R. A. Pollock, and L. E. 
Rosenberg. 1986. Targeting of pre-ornithine transcarbamylase to mito- 
chondria: definition of critical regions and residues in the leader peptide. 
Cell. 44:451-459. 
16. Horwich, A. L., F. Kalousek, I. Mellman, and L. E. Rosenherg. 1985. A 
leader peptide is sufficient to direct mitochondrial import of a chimeric 
protein. EMBO (Eur. Mol. Biol. Organ.)J.  4:1129-1135. 
17. Horwich, A. L., J. P. Kraus, K. Williams, F. Kalousek, W. Konigsherg, 
and L. E. Rosenberg. 1983. Molecular cloning of eDNA coding for rat 
ornithine transcarbamoylase. Proc.  Natl. Acad. Sci. USA. 80:4258- 
4262. 
18. Hurt, E., B. Pesold-Hurt, and G. Schatz. 1984. The amino terminal region 
of an imported mitocbondrial precursor polypeptide can direct cytoplas- 
mic dihydrofolate reductase into mitochondrial matrix. EMBO (Eur. Mol. 
Biol.  Organ.)J.  3:3149-3156. 
19. Kolansky, D. M., J. G. Conboy, W. A. Fenton, and L.  E.  Rosenberg. 
1982. Energy dependent translocation of the precursor of ornithine trans- 
carbamylase by  isolated  rat  liver mitochondria.  J.  Biol. Chem. 257: 
8467-8471. 
20. Kraus, J.  P., J.  G. Conboy, and L.  E.  Rosenberg.  1981.  Pre-ornithine 
transcarbamylase: properties of the cytoplasmic precursor of a mitochon- 
drial  matrix enzyme. J.  Biol. Chem. 256:10739-10742. 
21. Kraus, J. P., P. E. Hodges, C. L. Williamson, A. L. Horwich, F. Kalou- 
The Journal of Cell Biology, Volume 105,  1987  2638 sek, K. R. Williams, and L. E. Rosenberg. 1985. A eDNA clone for the 
precursor of rat mitochondrial ornithine transcarbamylase: comparison of 
rat and human leader sequences and conservation of catalytic sites. Nucl. 
Acids.  Res.  13:943-952. 
22. Lingelbach, K. R., L. J. Graf, A. R. Dunn, and N. J. Hoogenraad: 1986. 
Effect  of deletions within the leader peptide of pre-ornithine t.anscar- 
bamylase on mitochondrial import. Eur. J.  Biochem.  161:19-23. 
23, Miura, S., Y. Amaya, and M. Mori.  1986. A rnetalloprotease  involved in 
the processing of mitochondrial precursor proteins. Biochem.  Biophys. 
Res.  Commun.  134:1151-1159. 
24. Miura, S., M. Mori, Y. Amaya, and M. Tatibana. 1982. A mitochondrial 
protease  that cleaves the precursor of ornithine carbamyltransferase. 
Purification  and properties. Eur. J.  Biochem.  122:641-647. 
25. Mori, M., S. Miura, M. Tatibana, and P. P. Cohen, 1980. Characterization 
of a protease apparently involved in processing of pre-ornithine transcar- 
bamylase of rat liver. Proc.  Natl. Acad. Sci. USA. 77:7044-7048. 
26. Mori, M., T. Morita, S. Miura, and M. Tatibana. 1981.  Uptake and pro- 
cessing of the precursor for rat liver ornithine transcarbamylase by iso- 
lated  mitochondria. J.  Biol. Chem. 256:8263-8266. 
27. Nguyen, M., C. Argan, C. J. Lusty, and G. C. Shore.  1986. Import and 
processing of hybrid proteins by mammalian mitochondria in vitro. J. 
Biol.  Chem. 261:800-805. 
28. Nguyen, M., C. Argan, W. P. Sheffield, A. W. Bell, D. Shields, and G. C. 
Shore. 1987. A signal sequence domain essential for processing, but not 
import, of mitochondrial pre-ornithine carbamyl transferase. J. Cell Biol. 
104:1193-1198. 
29. Ohashi, A., J. Gibson, I. Gregor, and G. Schatz. 1982. Import of proteins 
into mitochondria. The precursor of cytochrome c~ is processed in two 
steps, one of them heme-dependent. J. Bhgl. Chem. 257:13042-13047. 
30. Pfanner, N., M. Tropschug, and W. Neupert. 1987. Mitochondrial protein 
import:  Nucleoside triphosphates are  involved in  conferring import- 
competence to precursors. Cell. 49:815-823. 
31. Reid, G. A., and G. Schatz.  1982.  Import of proteins into mitochondria. 
Extramitochondrial pools and posttranslational import of mitochondrial 
protein precursors in vivo. J.  Biol. Chem. 257:13062-13067. 
32. Reid, G. A., T. Yonetani, and G. Sehatz.  1982. Import of proteins into mi- 
tochondria. Import and maturation of the mitochondrial intermembrane 
space enzymes cytochrome b2 and cytochrome c  peroxidase in intact 
yeast cells. J.  Biol. Chem. 257:13068-13074. 
33. Rosenberg, L. E., W. A. Fenton, A. L. Horwieh, F. Kalousek, and J. P. 
Kraus. 1987. Targeting of nuclear-encoded proteins to the mitochondrial 
matrix:  implications for human genetic defects. Ann.  NY Acad. Sci. 
488:99-108. 
34. Sanger, F., and A. R. Coulson. 1975. A rapid method for determining se- 
quences in DNA by primed synthesis with DNA polymerase. J.  Mol. 
Biol.  94:441-446. 
35. Schatz, G., and R. Butow. 1983. How are proteins imported into mitochon- 
dria.  Cell. 32:316-318. 
36. Schleyer, M., and W. Neupert. 1986. Transport of proteins into mitochon- 
dria: translocational intermediates spanning contact sites between outer 
and inner membranes. Cell. 43:339-350. 
37. Schmidt, B., E. Wachter, W. Sebald, and W. Neupert. 1984.  Processing 
peptidase of Neurospora mitochondria. Two-step cleavage of imported 
ATPase subunit 9. Eur. J.  Biochem.  144:581-588. 
38. Traktman, P., and D. Baltimore.  1982.  Protease bypass of temperature- 
sensitive murine leukemia virus maturation mutants. J.  Virol. 44:1039- 
1046. 
39. vanLoon, A. P. G. M., and E. T. Young. 1986. Intracellular sorting of al- 
cohol dehydrogenase isoenzymes  in yeast: a cytosolic location reflect ab- 
sence of an amino-terminal targeting sequence for the mitochondrion. 
EMBO  (Eur. Mol. Biol. Organ.)J.  5:161-165. 
40. Wallace, R. A., D. W. Jared, J. N. Dumont, and M. W. Sega. 1973. Pro- 
tein incorporation by isolated  amphibian oocytes. III.  Optimum incuba- 
tion conditions. J.  Exp. Zool.  184:321-333. 
Sztul et al. Import of OTC inw Mitochondria  2639 